RoadPrintz Inc., with technology created at CWRU, secures additional funding to advance robotic street-painting vehicle
Following a fall 2019 license agreement between RoadPrintz Inc. and Case Western Reserve University, the company is now...
Technology Transfer Office
Medical device developed by CWRU/UH researchers wins 2020 Edison Award
A medical device based on technology developed by three faculty members from Case Western Reserve University and University...
Technology Transfer Office, Engineering’s Wyatt Newman collaborate with local company to improve road printing
CWRU hopes a local company is on the road to producing a safer, faster street-painting system Crain’s Cleveland...
Case Western Reserve University and RoadPrintz Inc. sign license agreement to advance robotic street-painting technology
Automated truck invention makes road-painting safer, faster, cheaper A new invention by a former Cleveland Heights auto repair-shop...
CollaMedix—biotech startup founded with technology invented at Case Western Reserve and University Hospitals—reaches exclusive licensing agreement
New technology, jointly created by Case Western Reserve University and University Hospitals Cleveland Medical Center, offers a promising...
Case Western Reserve University and Akouos sign exclusive licensing agreement to advance development of gene therapy technology as a potential treatment for a type of Usher syndrome
Case Western Reserve University and Boston-based Akouos have entered into an exclusive licensing agreement to develop a patented...
Company founded by CWRU’s Paul Tesar, Drew Adams partners with Genentech
CWRU spinout Convelo partners with San Francisco company to develop medicines for neurological disorders Crain’s Cleveland Business: A...
Case Western Reserve ‘spinout’ company, Convelo Therapeutics, partners with Genentech to develop medicines for neurological disorders
Convelo Therapeutics Inc., a Cleveland company based on the research findings of Paul Tesar and Drew Adams at...
Case Western Reserve University startup, NervGen Pharma, raises $7.5M from initial public offering
NervGen Pharma Corp., a Vancouver-based company founded to develop regenerative-medicine technology licensed from Case Western Reserve University, raised...
CWRU receives third-straight $500,000 technology start-up fund award from Ohio Third Frontier Commission
Only Ohio institution to receive funding all three years The Ohio Third Frontier Commission has awarded Case Western...